COVID‐19: Clinical status of vaccine development to date
S Kumar, M Basu, P Ghosh, A Ansari… - British Journal of …, 2023 - Wiley Online Library
Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2)‐induced COVID‐19 is a
complicated disease. Clinicians are continuously facing difficulties to treat infected patients …
complicated disease. Clinicians are continuously facing difficulties to treat infected patients …
A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases
Z Hamidi, S Jabraeili-Siahroud, Y Taati-Alamdari… - Virology Journal, 2023 - Springer
After the first reporting of the index case of Severe Acute Respiratory Syndrome (SARS)-CoV-
2-associated disease at the end of December 2019, the virus spread quickly throughout the …
2-associated disease at the end of December 2019, the virus spread quickly throughout the …
Characterization of the antispike IgG immune response to COVID-19 vaccines in people with a wide variety of immunodeficiencies
M Zendt, FA Bustos Carrillo, S Kelly, T Saturday… - Science …, 2023 - science.org
Research on coronavirus disease 2019 vaccination in immune-deficient/disordered people
(IDP) has focused on cancer and organ transplantation populations. In a prospective cohort …
(IDP) has focused on cancer and organ transplantation populations. In a prospective cohort …
Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic
Objective Antitumour necrosis factor (TNF) drugs impair serological responses following
SARS-CoV-2 vaccination. We sought to assess if a third dose of a messenger RNA (mRNA) …
SARS-CoV-2 vaccination. We sought to assess if a third dose of a messenger RNA (mRNA) …
COVID-19 infection and hospitalization risk according to vaccination status and DMARD treatment in patients with rheumatoid arthritis
Objectives The objectives of this study were to investigate the incidence of COVID-19
hospitalization in unvaccinated and vaccinated patients with RA compared with matched …
hospitalization in unvaccinated and vaccinated patients with RA compared with matched …
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study
KH Bjørlykke, HS Ørbo, AT Tveter, I Jyssum… - The Lancet …, 2023 - thelancet.com
Background Data on response and safety of repeated vaccinations and hybrid immunity in
patients with immune-mediated inflammatory diseases on immunosuppressive therapy is …
patients with immune-mediated inflammatory diseases on immunosuppressive therapy is …
Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals
Z Szekanecz, Z Vokó, O Surján, É Rákóczi… - Frontiers in …, 2023 - frontiersin.org
Introduction In Hungary, the HUN-VE 3 study determined the comparative effectiveness of
various primary and booster vaccination strategies during the Delta COVID-19 wave. That …
various primary and booster vaccination strategies during the Delta COVID-19 wave. That …
A deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases …
F Kharouf, T Eviatar, M Braun… - Frontiers in …, 2023 - frontiersin.org
Objective We aimed to characterize the course of COVID-19 in autoimmune inflammatory
rheumatic disease (AIIRD) patients in Israel, taking into consideration several remarkable …
rheumatic disease (AIIRD) patients in Israel, taking into consideration several remarkable …
Third and fourth vaccine doses broaden and prolong immunity to SARS-CoV-2 in adult patients with immune-mediated inflammatory diseases
MW Cheung, RM Dayam, JR Shapiro… - The Journal of …, 2023 - journals.aai.org
Previous studies have reported impaired humoral responses after SARS-CoV-2 mRNA
vaccination in patients with immune-mediated inflammatory diseases (IMIDs), particularly …
vaccination in patients with immune-mediated inflammatory diseases (IMIDs), particularly …
Hydroxychloroquine reduces T cells activation recall antigen responses
MM Kowatsch, J Lajoie, L Mwangi, K Omollo, J Oyugi… - PLoS …, 2023 - journals.plos.org
Background In the context of the current COVID-19 pandemic, there is still limited
information about how people suffering from autoimmune diseases respond to the different …
information about how people suffering from autoimmune diseases respond to the different …